FDA — authorised 13 September 2024
- Application: BLA761306
- Marketing authorisation holder: ELI LILLY AND CO
- Local brand name: EBGLYSS
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 EBGLYSS in United States
FDA authorised EBGLYSS on 13 September 2024
Marketing authorisations
FDA
- Status: approved
EBGLYSS in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is EBGLYSS approved in United States?
Yes. FDA authorised it on 13 September 2024; FDA has authorised it.
Who is the marketing authorisation holder for EBGLYSS in United States?
ELI LILLY AND CO holds the US marketing authorisation.